Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth

BACKGROUND: Current administration of hydroxyprogesterone caproate (HPC) by intramuscular injection is associated with limitations, including the potential for human error and contamination, patient anxiety, and increased risk of needlestick injury. OBJECTIVE: To describe the design of an auto-injec...

Descripción completa

Detalles Bibliográficos
Autores principales: Travanty, Michael N, Calawa, Bryon, Shalaby, Waleed S, Jozwiakowski, Michael J, Haraldsen, Kyle B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064158/
https://www.ncbi.nlm.nih.gov/pubmed/30100767
http://dx.doi.org/10.2147/MDER.S157114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064158/
https://www.ncbi.nlm.nih.gov/pubmed/30100767
http://dx.doi.org/10.2147/MDER.S157114

Ejemplares similares